tiprankstipranks
Advertisement
Advertisement

SGMT Stock Latest News

Sagimet Biosciences price target raised to $49 from $28 at Canaccord
The FlySagimet Biosciences price target raised to $49 from $28 at Canaccord
3h ago
SGMT
Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer
PremiumThe Fly
Sagimet Biosciences price target raised to $33 from $28 at Oppenheimer
3d ago
SGMT
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
PremiumRatings
Sagimet Therapeutics: Buy Rating Reiterated on Denifanstat’s First-Line Acne Potential; $28 Price Target Unchanged
3d ago
SGMT
Sagimet Biosciences management to meet virtually with Clear Street
PremiumThe Fly
Sagimet Biosciences management to meet virtually with Clear Street
4d ago
SGMT
Sagimet Biosciences price target lowered to $25 from $27 at Guggenheim
PremiumThe Fly
Sagimet Biosciences price target lowered to $25 from $27 at Guggenheim
5d ago
SGMT
3 Penny Stocks to Watch Now, 4/28/26
PremiumMarket News3 Penny Stocks to Watch Now, 4/28/26
6d ago
HTCO
SGMT
Sagimet Biosciences holds a conference call
Premium
The Fly
Sagimet Biosciences holds a conference call
6d ago
SGMT
TD Cowen establishes $21 price target for Sagamet Bioscinces
Premium
The Fly
TD Cowen establishes $21 price target for Sagamet Bioscinces
6d ago
SGMT
Sagimet Biosciences Announces Major Equity Offering for Pipeline
PremiumCompany Announcements
Sagimet Biosciences Announces Major Equity Offering for Pipeline
6d ago
8K
SGMT
Sagimet Updates Investor Presentation After Key Clinical Milestones
PremiumCompany Announcements
Sagimet Updates Investor Presentation After Key Clinical Milestones
7d ago
8K
SGMT
Sagimet Highlights Pipeline Progress and Strategic Corporate Developments
PremiumCompany Announcements
Sagimet Highlights Pipeline Progress and Strategic Corporate Developments
7d ago
8K
SGMT
Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer
PremiumCompany Announcements
Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer
13d ago
8K
SGMT
Sagimet Biosciences appoints Grauer as Chief Medical Officer
PremiumThe FlySagimet Biosciences appoints Grauer as Chief Medical Officer
14d ago
OMER
SGMT
Sagimet Biosciences initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Sagimet Biosciences initiated with a Buy at Rodman & Renshaw
1M ago
SGMT
Sagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target
Premium
Ratings
Sagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target
2M ago
SGMT
Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating
PremiumRatings
Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating
2M ago
SGMT
Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating
PremiumRatings
Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating
2M ago
SGMT
Sagimet Biosciences Reports 2025 Results, Highlights Clinical Progress
PremiumCompany Announcements
Sagimet Biosciences Reports 2025 Results, Highlights Clinical Progress
2M ago
8K
SGMT
Sagimet Biosciences reports Q4 EPS (29c), consensus (43c)
PremiumThe Fly
Sagimet Biosciences reports Q4 EPS (29c), consensus (43c)
2M ago
SGMT
Adobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
PremiumThe FlyAdobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
3M ago
V
MA
Sagimet Biosciences initiated with a Buy at Guggenheim
Premium
The Fly
Sagimet Biosciences initiated with a Buy at Guggenheim
3M ago
SGMT
Sagimet Biosciences price target raised to $37 from $29 at Clear Street
Premium
The Fly
Sagimet Biosciences price target raised to $37 from $29 at Clear Street
3M ago
SGMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >